Objective:The aim of this trial is to assess effects of Kieember and Yashili infant formula on body growth, behavior development, intestinal comfort, infectious diseases, allergic diseases, the absorption of nutrients and gut microbiota as compared to breast-milk in term infants aged 0-3 months. Participants:144 healthy term infants aged less than 30 days at entry to study. Study Design: A open-label,parallel, controlled trial. Arms, Groups, and Intervention: (1) Breast milk-fed group: fed with human breast milk; (2) Breast Milk Simulated Formula Group:fed with breast milk simulated infant formula (Ruibuen®Kieember, Phase I); (3) Traditional Formula Group: fed with traditional infant formula (Ruibuen®Yashili, Phase I). Intervention Duration: 90 days. Visits: 1month and 3month old. Outcome measures: (1)Biochemical detection of feces (total fat, fatty acids, calcium, nitrogen);(2)Stool characteristics (frequency, color, volume, and stool consistency);(3)Anthropometric parameters (body length, body weight, and head circumferences);(4)Temperament and adaptive behavior;(5)Gut microbiota;(6)General health and wellbeing;(7)concomitant medications and adverse events.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
179
Breast milk: Human breast milk, provided and fed by the corresponding infant's mother
Kieember Infant formula, Ruibuen®: a type of Phase I infant formula for 0-6 month infants, with a trademark of Ruibuen®. The formula is characterized by (1) OPO structured lipid of the third generation; and (2) Breast Milk Simulated complete structured lipid UPU. It was produced by Yashili New Zealand Dairy Co., Limited
Yashili Infant formula, Ruibuen®: a type of Phase I infant formula for 0-6 month infants, with a trademark of Ruibuen®. The formula is characterized by(1) lactoferrin and(2) lutein . It was produced by Yashili International Holdings Ltd.,China
Sun Yat-sen University
Guangzhou, Guangdong, China
Average Change Rate of Gut Microbiota Pattern Score from 1month to 3 month
Slope of change at 1 and 3 month in gut microbiota pattern score from 16S RNA sequencing.
Time frame: 1,3 months
Average Change Rate of Fecal Residual Fatty Acid from 1month to 3 month
Slope of change at 1 and 3 month in Fecal Residual Fatty Acid.
Time frame: 1,3 months
Average Change Rate of Fecal Residual Nitrogen from 1month to 3 month
Slope of change at 1 and 3 month in Fecal Residual Nitrogen.
Time frame: 1,3 months
Average Change Rate of Fecal Residual Calcium from 1month to 3 month
Slope of change at 1 and 3 month in fecal residual calcium.
Time frame: 1,3 months
Average Change Rate of body length from 1month to 3 month
Slope of change at 1 and 3 month in body length.
Time frame: 1,3 months
Average Change Rate of body weight from 1month to 3 month
Slope of change at 1 and 3 month in body weigh.
Time frame: 1,3 months
Average Change Rate of head circumferences from 1month to 3 month
Slope of change at 1 and 3 month in head circumferences.
Time frame: 1,3 months
Average Change Rate of Stool Characteristic Index from 1month to 3 month
Slope of change at 1 and 3 month in Stool Characteristic Index: calculated by using stool color (using sample pictures), stool shape (using sample pictures), and frequency.
Time frame: 1,3 months
Average Change Rate of an Index of General health and wellbeing from 1month to 3 month
Slope of change at 1 and 3 month in Index of General health and wellbeing, calculated from diseases (cold, diarrhea,infectious diseases), doctor visits, concomitant medications,etc.
Time frame: 1,3 months
Average Change Rate of Temperament Score from 1month to 3 month
Slope of change at 1 and 3 month in Temperament Score assessed by the Early Infant Temperament Scale
Time frame: 1,3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.